CC BY 4.0 · Journal of Child Science 2020; 10(01): e159-e162
DOI: 10.1055/s-0040-1718562
Case Report

Acetazolamide-Triggered Acute Flaccid Paralysis and Toxic-Metabolic Encephalopathy in a Toddler with Gastroenteritis: A Case Report

Jack Green
1   Division of Pediatric Critical Care, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, United States
,
Pooja Nawathe
1   Division of Pediatric Critical Care, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, United States
› Institutsangaben

Abstract

Acetazolamide is an infrequently prescribed medication in the outpatient pediatric setting, as one of its major indications is for the treatment of glaucoma, which is a largely adult disease. Though incredibly rare, serious neurologic side effects such as stroke, flaccid paralysis, and coma can occur after its administration. This case presentation of acute flaccid paralysis with metabolic derangement underscores the unusual, yet possible, toxic-metabolic and neurologic sequelae that can occur in an already acidotic host (in this case, caused by gastroenteritis) with acetazolamide ingestion. Life-threatening conditions must always be ruled out in patients who present with encephalopathy, but a medication history was crucial in clinching this case's unifying diagnosis. While there are case reports highlighting the rare central nervous system toxicities associated with acetazolamide ingestion, to our knowledge, none exist in the pediatric literature.

Disclosure

Authorization for the use or disclosure of health information for case report publication was signed by the guardian.




Publikationsverlauf

Eingereicht: 01. Juli 2020

Angenommen: 08. September 2020

Artikel online veröffentlicht:
02. November 2020

© 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 López C, Alcaraz AJ, Toledo B, Cortejoso L, Gil-Ruiz MA. Acetazolamide therapy for metabolic alkalosis in pediatric intensive care patients. Pediatr Crit Care Med 2016; 17 (12) e551-e558
  • 2 Heller I, Halevy J, Cohen S, Theodor E. Significant metabolic acidosis induced by acetazolamide. Not a rare complication. Arch Intern Med 1985; 145 (10) 1815-1817
  • 3 Goto S, Nosaka N, Yorifuji T. et al. Epidemiology of pediatric acute encephalitis/encephalopathy in Japan. Acta Med Okayama 2018; 72 (04) 351-357
  • 4 Mendes TM. Stroke mimic caused by acetazolamide. Eur J Case Rep Intern Med 2018; 5 (05) 000822
  • 5 Schwenk MH, St Peter WL, Meese MG, Singhal PC. Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Pharmacotherapy 1995; 15 (04) 522-527
  • 6 Boylan GB, Kharoshankaya L, Mathieson SR. Diagnosis of seizures and encephalopathy using conventional EEG and amplitude integrated EEG. Handb Clin Neurol 2019; 162: 363-400
  • 7 West TW. Transverse myelitis--a review of the presentation, diagnosis, and initial management. Discov Med 2013; 16 (88) 167-177
  • 8 Illes Z, Blaabjerg M. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies. Handb Clin Neurol 2017; 146: 125-138
  • 9 Pohl D, Alper G, Van Haren K. et al. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology 2016; 87 (09) (Suppl. 02) S38-S45
  • 10 Incecik F, Hergüner MO, Altunbaşak S, Solgun H. Acute encephalopathy associated rotavirus gastroenteritis. J Pediatr Neurosci 2009; 4 (02) 141-143
  • 11 Özalp E, Aydın-Teke T, Tanır G, Özkan M, Bayhan GI. Transient acute flaccid paralysis and seizures associated with rotavirus gastroenteritis in a child. Turk J Pediatr 2012; 54 (06) 661-663
  • 12 Kawamura Y, Ohashi M, Ihira M, Hashimoto S, Taniguchi K, Yoshikawa T. Nationwide survey of rotavirus-associated encephalopathy and sudden unexpected death in Japan. Brain Dev 2014; 36 (07) 601-607
  • 13 Messacar K, Abzug MJ, Dominguez SR. 2014 outbreak of enterovirus D68 in North America. J Med Virol 2016; 88 (05) 739-745
  • 14 Knoester M, Helfferich J, Poelman R, Van Leer-Buter C, Brouwer OF, Niesters HGM. 2016 EV-D68 AFM Working Group. Twenty-nine cases of Enterovirus-D68-associated acute flaccid myelitis in Europe 2016: a case series and epidemiologic overview. Pediatr Infect Dis J 2019; 38 (01) 16-21
  • 15 Filippi L, Bagnoli F, Margollicci M, Zammarchi E, Tronchin M, Rubaltelli FF. Pathogenic mechanism, prophylaxis, and therapy of symptomatic acidosis induced by acetazolamide. J Investig Med 2002; 50 (02) 125-132
  • 16 Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol Ther 1997; 74 (01) 1-20
  • 17 Schmickl CN, Owens RL, Orr JE, Edwards BA, Malhotra A. Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence. BMJ Open Respir Res 2020; 7 (01) e000557
  • 18 Portellos M, Buckley EG, Freedman SF. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS 1998; 2 (01) 43-47
  • 19 Sabri K, Levin AV. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma. J AAPOS 2006; 10 (05) 464-468
  • 20 Acetazolamide. In: Drug Dosages. Kahl LK, Hughes HK. , eds. Harriet Lane Handbook. Philadelphia, PA, USA: Elsevier; 2018
  • 21 Agrawal N, Jamshed N, Aggarwal P, Ekka M. Severe hypoglycemia masquerading as cerebellar stroke. J Family Med Prim Care 2014; 3 (04) 440-442
  • 22 Duarte J, Perez A, Coria F, Clavería LE, García MA. Hypoglycemia presenting as acute tetraplegia. Stroke 1993; 24 (01) 143
  • 23 Dollery SC. Therapeutic Drugs. London: Churchill Livingstone; 1991
  • 24 Inatani M, Yano I, Tanihara H, Ogura Y, Honda Y, Inui KI. Relationship between acetazolamide blood concentration and its side effects in glaucomatous patients. J Ocul Pharmacol Ther 1999; 15 (02) 97-105
  • 25 Wistrand PJ, Bååthe P. Inhibition of carbonic anhydrase activity of whole erythrocytes. Acta Pharmacol Toxicol (Copenh) 1968; 26 (02) 145-168